EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

Testosterone treatment combined with exercise to improve muscle strength, physical function and quality of life in men affected by inclusion body myositis: A randomised, double-blind, placebo-controlled, crossover trial

Sophia G Connor iD, Timothy J Fairchild, Yvonne C Learmonth, Kelly Beer, Ian Cooper, Glenn Boardman, Shaun Y M Teo iD, Behnaz Shatahmasseb, Rui Zhang, Krystyne Hiscock, Jerome D Coudert iD, Bu B Yeap und 1 weitere

PLOS ONE · 11.04.2023 · 18 (4) · e0283394

DOI: 10.1371/journal.pone.0283394 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift PLOS ONE, online erschienen am 11.04.2023. Verfasst von Sophia G Connor und 12 weiteren Autor:innen. Beteiligte Einrichtung: Royal Perth Hospital, Perth, Western Australia, Australia. Hauptthemen laut MEDLINE: Testosterone, Myositis, Inclusion Body. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Inclusion body myositis (IBM) is the most commonly acquired skeletal muscle disease of older adults involving both autoimmune attack and muscle degeneration. As exercise training can improve outcomes in IBM, this study assessed whether a combination of testosterone supplementation and exercise training would improve muscle strength, physical function and quality of life in men affected by IBM, more than exercise alone.

Methods

This pilot study was a single site randomised, double-blind, placebo-controlled, crossover study. Testosterone (exercise and testosterone cream) and placebo (exercise and placebo cream) were each delivered for 12 weeks, with a two-week wash-out between the two periods. The primary outcome measure was improvement in quadriceps isokinetic muscle strength. Secondary outcomes included assessment of isokinetic peak flexion force, walk capacity and patient reported outcomes, and other tests, comparing results between the placebo and testosterone arms. A 12-month Open Label Extension (OLE) was offered using the same outcome measures collected at 6 and 12-months.

Results

14 men completed the trial. There were no significant improvements in quadriceps extension strength or lean body mass, nor any of the secondary outcomes. Improvement in the RAND Short Form 36 patient reported outcome questionnaire ‘emotional wellbeing’ sub-category was reported during the testosterone arm compared to the placebo arm (mean difference [95% CI]: 6.0 points, [95% CI 1.7,10.3]). The OLE demonstrated relative disease stability over the 12-month period but with a higher number of testosterone-related adverse events.

Conclusions

Adding testosterone supplementation to exercise training did not significantly improve muscle strength or physical function over a 12-week intervention period, compared to exercise alone. However, the combination improved emotional well-being over this period, and relative stabilisation of disease was found during the 12-month OLE. A longer duration trial involving a larger group of participants is warranted.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TestosteroneMyositis, Inclusion BodyMaleHumansAgedCross-Over StudiesQuality of LifePilot ProjectsExerciseMuscle Strength

Substanzen

Testosterone

Autor:innen und Institutionen

  • Royal Perth Hospital, Perth, Western Australia, Australia.
  • Centre for Molecular Medicine & Innovative Therapeutics, Murdoch University, Murdoch, Western Australia, Australia.
  • Discipline of Exercise Science, Murdoch University, Murdoch, Western Australia, Australia.
  • Perron Institute of Neurological and Translational Sciences, Nedlands, Western Australia, Australia.
  • Research Development Unit, Fiona Stanley Hospital, Murdoch, Western Australia, Australia.
  • Department of Clinical Biochemistry, Pharmacology and Toxicology, PathWest Laboratory Medicine, QEII Medical Centre, Nedlands, WA, Australia.

ORCID-Profile: Sophia G Connor, Shaun Y M Teo, Jerome D Coudert

Zitieren

APA

Connor, S. G., Fairchild, T. J., Learmonth, Y. C., Beer, K., Cooper, I., Boardman, G., Teo, S. Y. M., Shatahmasseb, B., Zhang, R., Hiscock, K., Coudert, J. D., Yeap, B. B., & Needham, M. (2023). Testosterone treatment combined with exercise to improve muscle strength, physical function and quality of life in men affected by inclusion body myositis: A randomised, double-blind, placebo-controlled, crossover trial. PLOS ONE, 18(4), e0283394. https://doi.org/10.1371/journal.pone.0283394

Vancouver

Connor SG, Fairchild TJ, Learmonth YC, Beer K, Cooper I, Boardman G, et al. Testosterone treatment combined with exercise to improve muscle strength, physical function and quality of life in men affected by inclusion body myositis: A randomised, double-blind, placebo-controlled, crossover trial. PLOS ONE. 2023;18(4):e0283394. doi:10.1371/journal.pone.0283394

BibTeX
@article{Connor2023,
  author = {Connor, Sophia G and Fairchild, Timothy J and Learmonth, Yvonne C and Beer, Kelly and Cooper, Ian and Boardman, Glenn and Teo, Shaun Y M and Shatahmasseb, Behnaz and Zhang, Rui and Hiscock, Krystyne and Coudert, Jerome D and Yeap, Bu B and Needham, Merrilee},
  title = {Testosterone treatment combined with exercise to improve muscle strength, physical function and quality of life in men affected by inclusion body myositis: A randomised, double-blind, placebo-controlled, crossover trial},
  journal = {PLOS ONE},
  year = {2023},
  volume = {18},
  number = {4},
  pages = {e0283394},
  doi = {10.1371/journal.pone.0283394}
}
Kostenlos starten →